Sol-Gel Technologies (SLGL) Asset Utilization Ratio (2018 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Asset Utilization Ratio came in at 0.42 in Q1 2026, up 8.49% year-on-year from 0.38 in Q1 2025, and down 30.55% on a QoQ basis from 0.6 in Q4 2025.
Sol-Gel Technologies (SLGL) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 9 years of Asset Utilization Ratio data on file, last reported at 0.42 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 8.49% year-over-year to 0.42 in Q1 2026; TTM through Mar 2026 was 0.42, a 8.49% increase from a year earlier, with the FY2025 full-year figure at 0.59, up 107.31% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.42, down from 0.6 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for SLGL reached as high as 61.36 in Q4 2022 and fell as low as 0.02 in Q3 2023.
- Historically, Asset Utilization Ratio has averaged 14.97 across 5 years, with a median of 0.42 in 2026.
- Across the five-year window, Asset Utilization Ratio surged 56136.96% in 2022 and plunged 99.96% in 2023, its largest moves.
- Year by year, Asset Utilization Ratio stood at 61.36 in 2022, then plunged by 99.95% to 0.03 in 2023, then jumped by 926.91% to 0.29 in 2024, then jumped by 105.67% to 0.6 in 2025, then slumped by 30.55% to 0.42 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.42 in Q1 2026, 0.6 in Q4 2025, and 0.51 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.72 |
| Mar 31, 2025 | 0.38 |
| Dec 31, 2024 | 0.29 |
| Sep 30, 2024 | 0.27 |
| Jun 30, 2024 | 0.16 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.09 |
| Dec 31, 2022 | 61.36 |
| Sep 30, 2022 | 56.92 |
| Jun 30, 2022 | 54.50 |
| Mar 31, 2022 | 48.27 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.10 |
| Jun 30, 2021 | 0.12 |
| Mar 31, 2021 | 0.11 |
| Dec 31, 2020 | 0.14 |